References
Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC, Khalessi AA, Levy EI, Palesch YY, Prabhakaran S, Saposnik G, Saver JL, Smith EE, American Heart Association Stroke Council and Council on Epidemiology and Prevention (2016) Sientific rational for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 47(2):581–641
European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis. 25(5):457–507
Breuer L, Huttner HB, Kiphuth IC, Ringwald J, Hilz MJ, Schwab S, Köhrmann M (2013) Waiting for platelet counts causes unsubstantiated delay of thrombolysis therapy. Eur Neurol 69(5):317–320
Cucchiara BL, Jackson B, Weiner M, Messe SR (2007) Usefulness of checking platelet count before thrombolysis in acute ischemic stroke. Stroke 38:1639–1640
Smith EE, Fonarow GC, Reeves MJ, Cox M, Olson DM, Hernandez AF, Schwamm LH (2011) Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from get with the guidelines-stroke. Stroke 42:3110–3115
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This clinical report was written in compliance with the Helsinki Declaration.
Informed consent
Consent to publish case report was obtained from the patient.
Rights and permissions
About this article
Cite this article
De Piazza, C., Raudino, F. Thrombolysis in thrombocytopenic stroke patients: a case report. Acta Neurol Belg 117, 749–751 (2017). https://doi.org/10.1007/s13760-016-0720-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-016-0720-4